Kymera Therapeutics (KYMR)

Kymera Therapeutics (KYMR) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• KYMR last traded at $128.56, 1.52% on the day.
• Kymera Therapeutics: P/E -35.4, revenue $104.99M over the last four quarters.
• Over the past year KYMR returned 109.24%; year to date 65.22%.

Updated 2026-11-02 20:15 UTC